Download PDF
Horm Metab Res 2002; 34(2): 102-106
DOI: 10.1055/s-2002-20524
Original Clinical

© Georg Thieme Verlag Stuttgart · New York

Simplified Measurement of Insulin Sensitivity with the Minimal Model Procedure in Type 2 Diabetic Patients without Measurement of Insulinemia

A.  Pérez-Martin 1 , E.  Raynaud 1 , C.  Hentgen 1 , J.  Bringer 2 , J.  Mercier 1 , J.  F.  Brun 1
  • 1 Service Central de Physiologie Clinique, Unité CERAMM (Centre d’Exploration et de Réadaptation des Anomalies Métaboliques et Musculaires), Montpellier, France
  • 2 Service d’Endocrinologie, CHU Lapeyronie, Montpellier, France
Further Information

Publication History

18 June 2001

16 October 2001

Publication Date:
04 March 2002 (online)

Also available at
    Permissions and Reprints

Abstract

This study aimed to evaluate a simplified minimal model protocol for measuring insulin sensitivity in mild and severe type 2 diabetes, considering that changes in serum insulin during an insulin-modified intravenous glucose tolerance test almost only reflect the insulin injection. Two groups of diabetics treated with high doses of antidiabetic agents were recruited. Mean insulin responses were calculated in group 1 (n = 30). In group 2 (n = 38), we compared insulin sensitivity (SI) obtained with reference protocol with SI calculated by a minimal model procedure including the theoretical average insulin profile determined in group 1, and with Homeostasis Model Assessment (HOMA-R). Additionally, the cost of each procedure was calculated. SI measured by the reference method strongly correlated with SI determined by the simplified protocol (r = 0.966, p < 0.0001), while no correlation was found with HOMA-R (r = - 0.349, NS). Reduction of cost for HOMA-R and simplified minimal model procedure were - 92 and - 81 %, respectively. This simplified and relative inexpensive protocol, using minimal model procedure without insulin measurement, accurately measures SI regardless of β-cell defect degree. This approach could be of interest when limits of validity of simple indexes are reached.

Key words

Insulin Resistance - Type 2 Diabetes - Minimal Model - Basal Indexes - HOMA

  • 1 Reaven G M. Role of insulin resistance in human disease.  Diabetes. 1988;  37 1595-1607
    CrossrefPubMedGoogle Scholar
  • 2 Fujimoto W Y. The importance of insulin resistance in the pathogenesis of type 2 diabetes mellitus.  Am J Med. 2000;  108 (Suppl 6a) 9S-14S
    PubMedGoogle Scholar
  • 3 Kahn S E. The importance of the beta-cell in the pathogenesis of type 2 diabetes mellitus.  Am J Med. 2000;  108 (Suppl 6a) 2S-8S
    PubMedGoogle Scholar
  • 4 Cavaghan M K, Ehrmann D A, Polonsky K S. Interactions between insulin resistance and insulin secretion in the development of glucose intolerance.  J Clin Invest Aug. 2000;  106 (3) 329-333
    PubMedGoogle Scholar
  • 5 Haffner S M, Howard G, Mayer E, Bergman R N, Savage P J, Rewers M, Mykkänen L, Karter J, Hamman R, Saad M F. Insulin sensitivity and acute insulin response in African American, non Hispanic white, and Hispanics with NIDDM. The insulin resistance atherosclerosis study.  Diabetes. 1997;  46 63-69
    PubMedGoogle Scholar
  • 6 Gerich J E. Insulin resistance is not necessarily an essential component of type 2 diabetes.  J Clin Endocrinol Metab. 2000;  85 (6) 2113-2115
    CrossrefPubMedGoogle Scholar
  • 7 Saad M F, Anderson R L, Watanabe R M, Kades W W, Chen Y DI, Sands R E, Pei D, Savage P J, Bergman R N. A comparison between the minimal model and the glucose clamp in the assessment of insulin sensitivity across the spectrum of glucose tolerance.  Diabetes. 1994;  43 1114-1121
    PubMedGoogle Scholar
  • 8 Katsuki A, Sumida Y, Gabazza E C, Murashima S, Furuta M, Araki-Sasaki R, Hori Y, Yano Y, Adachi Y. Homeostasis model assessment is a reliable indicator of insulin resistance during follow-up of patients with type 2 diabetes.  Diabetes Care. 2001;  24 362-365
    PubMedGoogle Scholar
  • 9 Brun J F, Raynaud E, Mercier J. Homeostasis model assessment and related simplified evaluations of insulin sensitivity from fasting insulin and glucose: no need for log transformation but beware of the limits of validity.  Diabetes Care. 2000;  23 1037-1038
    PubMedGoogle Scholar
  • 10 Welch S, Gebhart S SP, Bergman R N, Phillips L S. Minimal model analysis of intravenous glucose tolerance test-derived insulin sensitivity in diabetic subjects.  J Clin Endocrinol Metab. 1990;  71 1508-1518
    CrossrefPubMedGoogle Scholar
  • 11 Yang Y J, Youn J A, Bergman R N. Modified protocols to improve insulin sensitivity estimation using the minimal model.  Am J Physiol. 1987;  253 595-602
    PubMedGoogle Scholar
  • 12 The expert Committee on the Diagnosis and classification of Diabetes mellitus . Report of the Expert Committee on the Diagnosis and Classification of Diabetes mellitus.  Diabetes Care. 1997;  10 1183-1197
    PubMedGoogle Scholar
  • 13 Brun J F, Guintrand-Hugret R, Boegner C, Bouix 0, Orsetti A. Influence of short submaximal exercise on parameters of glucose assimilation analyzed with the minimal model.  Metabolism. 1995;  44 833-840
    CrossrefPubMedGoogle Scholar
  • 14 Brun J F, Fédou C, Monnier J F, Jourdan N I, Orsetti A. Relationships between insulin resistance measured with the minimal model and microalbuminuria in type 2 (non-insulin dependent) diabetics.  Endocrinology and Metabolism. 1995;  2 203-213
    PubMedGoogle Scholar
  • 15 Raynaud E, Pérez-Martin A, Brun J F, Fédou C, Mercier J. Insulin sensitivity measured with the minimal model is higher in moderately overweight women with predominantly lower body fat.  Horm Metab Res. 1999;  31 415-417
    PubMedGoogle Scholar
  • 16 Matthews D R, Hosker J P, Rudenski A S, Naylor B A, Treacher D F, Turner R C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.  Diabetologia. 1985;  28 412-419
    Google Scholar
  • 17 Marquis P. Comparaisons de méthodes analytiques.  Ann Biol Clin. 1999;  57 737-738 (http://perso.easynet.fr/-philimar)
    PubMedGoogle Scholar
  • 18 Bland J M, Altman D G. Statistical methods for assessing agreement between two methods of clinical measurement.  Lancet. 1986;  i 307-310
    PubMedGoogle Scholar
  • 19 Foley J E, Chen Y D, Lardinois C K, Hollenbeck C B, Liu G C, Reaven G. Estimates of in vivo insulin action in humans: comparison of the insulin clamp and the minimal model techniques.  Horm Metab Res. 1985;  17 406-409
    PubMedGoogle Scholar
  • 20 Persson B, Edwall L, Hanson U, Nord E, Westgren M. Insulin sensitivity and insulin response in women with gestational diabetes mellitus.  Horm Metab Res. 1997;  29 393-397
    PubMedGoogle Scholar
  • 21 Bergman R N, Prager R, Volund A, Olefsky J M. Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp.  J Clin Invest. 1987;  79 790-800
    PubMedGoogle Scholar
  • 22 Emoto M, Nishizawa Y, Maekawa K, Hiura Y, Kanda H, Kawagishi Shoji T, Okuno Y, Morii H. Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas.  Diabetes Care. 1999;  22 818-822
    PubMedGoogle Scholar
  • 23 Bonora E, Targher G, Alberiche M, Bonadonna R C, Saggiani F, Zen M B, Monauni T, Muggeo M. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity.  Diabetes Care. 2000;  23 57-63
    CrossrefPubMedGoogle Scholar
  • 24 Kahn S E, Prigeon R L, McCulloch D K, Boyko E J, Bergman R N, Schwartz M W, Neifing J L, Ward W K, Beard J C, Palmer J P, Porte D R. Quantification of the relationship between insulin sensitivity and b-cell function in human subjects: evidence for a hyperbolic function.  Diabetes. 1993;  42 1663-1672
    CrossrefPubMedGoogle Scholar
  • 25 Mari A, Pacini G, Murphy E, Ludvik B, Nolan J J. A model-based method for assessing insulin sensitivity from the oral glucose tolerance test.  Diabetes Care. 2001;  24 539-548
    CrossrefPubMedGoogle Scholar

Antonia Pérez-Martin, M.D.

CERAMM-CHU Lapeyronie

34 295 Montpellier Cedex 5 · France

Phone: + 33 (0) 4 67 33 82 84

Fax: + 33 (0) 4 67 33 89 86

Email: a-perez_martin@chu-montpellier.fr

      >